Plasma B-Type Natriuretic Peptide Levels May Increase Because of Fat Mass Loss by Metformin or Sodium-Glucose Transporter 2 Inhibitors Treatment

Hidetaka Hamasaki, Hidekatsu Yanai
  • Journal of Endocrinology and Metabolism, January 2016, Elmer Press, Inc.
  • DOI: 10.14740/jem333w
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Hidetaka Hamasaki